Exchange: NASDAQ·Updated 07:30 PM EDT

IRTC News

News
all
press releases
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireNEW YORK, Oct. 13, 2026Shareholders are encouraged to contact the firm to discuss their rights and options at no...
PR Newswire
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?PR NewswireNEW YORK, Oct. 13, 2026Shareholders are encouraged to contact the firm to discuss their rights and options at no...
PR Newswire
More News
Should You Buy, Hold or Sell Tempus AI Stock Amid AI Boom?
TEM's strong data licensing growth, AI-driven innovations and rising shares favor holding the stock, but premium valuation and reimbursement risks warrant caution.
Zacks
Here's How Tempus AI is Capitalizing on AI-ECG Market Growth
TEM is expanding its cardiovascular portfolio with FDA-cleared AI-ECG tools targeting complex cardiac conditions.
Zacks
Butterfly Network (BFLY) Surges 22.0%: Is This an Indication of Further Gains?
Butterfly Network (BFLY) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Zacks
Here's Why You Should Retain IRTC Stock in Your Portfolio for Now
iRhythm's Q2 momentum, AI-driven predictive care and deeper EHR integration support growth, though reimbursement pressures remain.
Zacks
Should Investors Buy IRTC as Growth Improves but Risks Stay Elevated?
iRhythm's Q2 revenue growth, margin expansion and record free cash flow strengthen its case, but reimbursement and regulatory risks remain elevated.
Zacks
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, Aug. 17, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no...
PR Newswire
iRhythm to Acquire VitalConnect to Expand Cardiac Monitoring Platform
IRTC's VitalConnect deal expands its cardiac monitoring reach across ambulatory, inpatient and hospital-to-home care while opening new growth opportunities.
Zacks
Here's Why iRhythm Holdings, Inc. (IRTC) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks
iRhythm Q2 Earnings Beat Estimates on Volume Growth, '26 View Raised
IRTC posts 20.1% revenue growth, margin expansion and a higher 2026 outlook while advancing innovation and its Vital Connect acquisition.
Zacks

Advertisement|Remove ads.